Manufacturing

Biocon Biologics runs world-class manufacturing facilities in India and Malaysia to serve global healthcare needs at scale and speed. Our India sites include the largest facility in India dedicated to manufacturing monoclonal antibodies (mAbs). Our Johor, Malaysia plant is Asia’s largest integrated insulin manufacturing site — a global center of excellence that strengthens access to affordable insulins.

We have established expertise across microbial and mammalian platforms to produce a broad portfolio of insulins, mAbs and conjugated recombinant proteins.

We drive operational excellence through vertical integration, lean processes, and data analytics. Our facilities consistently meet the highest regulatory standards, with approvals from the U.S. Food and Drug Administration, European Medicines Agency (EMA), ANSM (France), HPRA (Ireland), ANVISA (Brazil), NPRA (Malaysia), Ministry of Health (Russia), MFDS (South Korea) and several others.

We also collaborate with trusted manufacturing partners worldwide, extending our reach and resilience.

Industry 4.0 technologies enhance our efficiency, agility and future readiness. These capabilities allow us to deliver high-quality biosimilars that address critical unmet medical needs across the globe.

Global Manufacturing Network for Drug Product Facilities

Drivers of Change

At Biocon Biologics, we're working every day to make insulins available, affordable and accessible, for all who need them. Our state-of-the-art facility in Johor Bahru, Malaysia, stands as a global Center of Excellence for insulins – a symbol of innovation, purpose, and commitment.
Related Links

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics EU Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics U.S. Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Leaving the Biocon Biologics site

You are now leaving the Biocon Biologics page for a Biocon Biologics affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.